IBS CLINICAL STUDY
Irritable Bowel Syndrome is a digestive disorder associated with a range of symptoms that vary from person to person and can significantly reduce the quality of life. ENBIOSIS IBS clinical study success rate is 78%. It is the first and only successful IBS management in Turkey that utilizedmicrobiome-specific personalized nutrition recommendations.
Clinical Study of Chronic Constipation
ENBIOSIS chronic constipation clinical study success rate is 83%. The study was accepted to the European Society of Coloproctology congress.